Study on Ketamine vs Fentanyl for Pain Management in Laparoscopic Cholecystectomy
A randomized double-blind study is comparing intraperitoneal ketamine and fentanyl as adjuvants to bupivacaine for postoperative pain control in laparoscopic cholecystectomy.
Phase III
Anesthesia / Pain Management
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
If ketamine proves more effective, it may shift clinical practice towards its use, affecting sales of current analgesics like fentanyl.
Why it matters
This clinical trial could significantly impact postoperative pain management protocols, potentially favoring ketamine over traditional analgesics like fentanyl. A shift in clinical practice could alter market dynamics and influence the competitive landscape for pain management solutions.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results of the trial for efficacy data and subsequent changes in clinical guidelines for postoperative pain management.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.